CIEM

CIEM (Center for Innovation in Early Medicine) is the primary early-stage research and development hub for UCB, a global biopharmaceutical company. Located in Slough, United Kingdom, CIEM focuses on the discovery and development of novel therapeutic solutions for severe diseases in immunology and neurology. The center integrates advanced drug discovery technologies, including small molecule and antibody engineering, to transition high-potential programs from discovery through early clinical proof-of-concept. CIEM plays a critical role in UCB's strategy to deliver patient-centric medicines by leveraging deep scientific expertise in protein structure and disease biology.